Brentuximab Vedotin, Cyclosporine, and Verapamil Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Clinical trial NCT03013933 · COMPLETED
Trial details
- NCT number
- NCT03013933
- Sponsor
- City of Hope Medical Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-03
- Primary completion
- 2022-05-24
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.